The Sleeping Beauty (SB) transposon (Tn) system is a nonviral gene delivery tool that has widespread application for transfer of therapeutic genes into the mammalian genome. To determine its utility as a gene delivery system, it was important to assess the epigenetic modifications associated with SB insertion into the genome and potential inactivation of the transgene. This study investigated the DNA methylation pattern of an SB Tn as well as the flanking genomic region at insertion sites in the mouse genome. The ubiquitous ROSA26 promoter and an initial part of the eGFP coding sequence in the SB Tn exhibited high levels of CpG methylation in transgenic mouse lines, irrespective of the chromosomal loci of the insertion sites. In contrast, no detectable CpG methylation in the endogenous mouse ROSA26 counterpart was observed in the same animals. Furthermore, significant hypomethylation was detected in neighboring chromosomal sequences of two unique SB Tn insertions compared to wild-type patterns. Taken together, these results suggest that SB Tn insertions into the mouse genome can be discriminated by DNA methylation machinery from an identical endogenous DNA sequence and can profoundly alter the DNA methylation status of the transgene cargo as well as flanking host genomic regions.
The Sleeping Beauty (SB) transposon (Tn) is a mobile DNA element resurrected by genetic correction of accumulated mutations using a consensus sequence derived from inactive salmonoid-type members of the Tc1/mariner superfamily of transposons [1] . The native form of the SB Tn consisted of terminal inverted repeat/direct repeat sequences (IR/DRs) flanking a gene encoding the obligate SB transposase that mediates the insertion of the Tn into the host genome by a cut-and-paste mechanism. For gene delivery or other applications such as insertional mutagenesis, the transgene cassette for genomic insertion is located between the IR/DRs, replacing the SB transposase gene that is supplied as either a separate transgene or mRNA. Target sites of SB transposition are invariably TA dinucleotides that are duplicated during the insertion of the SB Tn. It has been shown that the SB Tn system is functional in cultured mammalian cells [1] , mouse ES cells [2] , mouse liver [3] , mouse germ lines [4] , and single-cell embryos [5] , suggesting no indispensable host cofactors.
The potential of SB for delivering and stably integrating a transgene into the mammalian host genome has been demonstrated in vitro as well as in vivo [1, 3] . If the SB Tn is to be used for therapeutic gene delivery, it is critical to ensure the longterm, stable expression of the transposed transgene within the host genome. Heterologous DNA elements introduced into the mammalian genome by various gene delivery systems are frequently inactivated by de novo DNA methylation [6] [7] [8] . The long terminal repeat (LTR) sequences of many retroviral vectors are targets for de novo DNA methylation, which can lead to silencing of transgenes or proviruses [6, 7, 9] . DNA methylation is closely associated with the transcriptional repression of many mammalian genes [10] . The direct correlation between repression of retroviruses in the host genome and mammalian CpG methylation has been confirmed by reactivation following treatments that induce genome-wide demethylation [11, 12] . Mammalian CpG methylation appears to play an essential role in the transcriptional regulation of many critical genes involved in development, genomic imprinting, and carcinogenesis. In fact, partial or complete lack of DNA methyltransferase activity results in dramatic changes associated with those biological processes [13] [14] [15] . Reactivation of silent retroviral or retrotransposon elements due to the lack of DNA methylation suggests that it may have evolved as a basic defense mechanism to prevent the harmful activity of mobile DNA elements within the mammalian genome [16, 17] .
Previous studies of SB have focused on applications for therapeutic gene delivery [3, 18] , improvement of insertion efficiency [19, 20] , and the utilization of SB for insertional mutagenesis in mouse [2, 4, 21, 22] . Moreover, the precise target site preference of SB-mediated insertion has also been studied extensively to evaluate the possible application of the SB Tn system for clinical gene therapy [23] [24] [25] . While viral vectors exhibit a clear preference for transcriptionally active regions as their target sites for integration [26, 27] , SB has displayed either no significant preference for actively transcribed regions in the host genome [21, 24] or a very weak insertional bias toward transcriptional units [25] . Most recently, SB has been used for cancer gene discovery in the mouse genome in all tissue types [28] . Thus, in addition to issues related to delivery and transposition of a transgene by SB, it is essential to characterize the potential epigenetic modifications at the site of insertion as well as within the flanking chromosomal regions. Epigenetic changes such as DNA methylation could significantly influence the transcriptional activity of the Tn transgene cargo and the adjacent host genomic regions.
To identify a potential relationship between SB transposition and DNA methylation, we investigated the CpG methylation status of an inserted transgene (T/MPT-eGFP) and host genomic flanking regions by bisulfite-mediated sequencing [29] . Our results revealed that SB Tns inserted into the mouse genome were heavily methylated in the ROSA26 promoter [30, 31] and eGFP (enhanced and farnesylated green fluorescent protein) reporter gene, both of which were contained in SB. However, the endogenous mouse ROSA26 promoter located at the native chromosomal locus was devoid of CpG methylation in the same transgenic animals carrying SB insertions. This is strong evidence to suggest that the host cellular epigenetic modification system can distinguish between an endogenous genomic sequence and the exogenous counterpart inserted via SB. In addition, we detected hypomethylation or complete absence of CpG methylation at two host genomic flanking regions that were methylated in the wild-type mice. These results indicate that SB Tns inserted into the mammalian genome can be the target for significant modification of DNA methylation, potentially altering gene expression.
Results

Transgenic mice generated with SB insertions in their genome
An SB Tn, T/MPT-eGFP, was originally constructed for polyadenylation (poly(A))-gene-trap mutagenesis in mice (MPT) [21, 22] . Its mutagenic nature stems from its cargo of a splice acceptor, followed by stop codons in all three open reading frames (ORFs), and a poly(A) signal that disrupts transcription of an endogenous gene when T/MPT-eGFP is inserted within an intron in the correct polarity relative to its genomic promoter (Fig. 1A) . As a reporter gene, eGFP was incorporated into the construct under control of the ROSA26 promoter, which facilitates broad expression of transgenes in mice [30, 31] . The downstream splice donor was designed to connect the eGFP ORF, which was devoid of its own poly(A) signal, to an endogenous exon when the T/MPT-eGFP was inserted into an intron in proper transcriptional orientation.
Doubly transgenic mice on a genetic background of the FVB/n inbred strain were generated by crossing mice carrying multicopy T/MPT-eGFP concatemer arrays on chromosome 9 with CAGGS-SB10 transgenic mice that expressed the SB10 transposase ubiquitously [22] . These doubly transgenic male Fig. 1 . Schematic map of the T/MPT-eGFP Tn and generation of transgenic mice with mobilization of the SB Tn. (A) T/MPT-eGFP consists of typical IR/DR sequences of SB at both ends, a splice acceptor (SA), a polyadenylation sequence (pA), the ROSA26 promoter (black box), eGFP as the reporter gene, and a splice donor (SD). (B) Doubly transgenic FVB/n mice were created by crossing transgenic mice carrying a multicopy concatemer of T/MPT-eGFP on chromosome 9 with mice carrying an SB10 transposase transgene on chromosome 3. Outcrossing the doubly transgenic male mice to wild-type female mice of the FVB/n strain resulted in progeny that had T/MPT-eGFP SB insertions transposed from the original locus on chromosome 9 to other loci in the mouse genome by the action of the SB10 transposase in the germ line of the T/MPT-eGFP/SB10 males. The progeny carrying the new insertions were further bred to generate the homo-or heterozygous animals for each of the different integrations investigated in this study. mice were outcrossed with wild-type FVB/n females yielding progeny harboring the T/MPT-eGFP SB Tn mobilized from the original locus of chromosome 9 in the germ-line cells of the parental male mice (Fig. 1B) . The new insertion sites of T/MPTeGFP were identified by splinkerette PCR [21] . The progeny with novel insertion sites were subsequently bred on an FVB/n background to generate mice heterozygous or homozygous for a single unique SB insertion in the genome. In this study, transgenic mice harboring one of the T/MPT-eGFP insertions designated, 01-0001, 01-0006, 01-0009, 01-0024, 01-0032, and 01-0041, were used [21] . Each of these insertions was flanked by duplicated TA dinucleotides, which are the hallmark of SB10-mediated transposition. Host genomic DNA sequences adjacent to each insertion site investigated in this study are accessible through the SB Tn database (http://mouse.ccgb.umn. edu/transposon) [32] .
High levels of DNA methylation within the inserted SB Tns DNA methylation of immediate early promoters has been shown to be important in regulating the transcriptional activity of many mammalian genes [33, 34] . Thus, to determine whether an SB Tn inserted in the mouse genome was susceptible to selective CpG methylation, genomic DNA isolated from tail clips of T/MPT-eGFP transgenic mice was subjected to bisulfite-mediated genomic sequencing [35, 36] . By sequence analysis using the Methprimer program [37] , we identified an ∼1.7-kb region encompassing ROSA26 and eGFP of the T/ MPT-eGFP as a large CpG island [38] . We investigated the DNA methylation status of ROSA26 and eGFP-coding sequence with bisulfite-PCR primers spanning a 3′ region of the immediate early ROSA26 promoter (∼320 bp) and a 5′ region of eGFP (∼170 bp) that contained a total of 57 CpG dinucleotides. In all the inserted T/MPT-eGFP Tns characterized by each distinct chromosomal position, the eGFP-coding sequence and the 12 CpGs of ROSA26 at the boundary between ROSA26 and eGFP were heavily methylated (Fig. 2) . The remaining portion of the ROSA26 promoter region examined was also extensively methylated except for the Tns inserted in chromosomes 7 and 9, indicating that the level of CpG methylation is modulated according to chromosomal locus or genomic environment of SB insertion. Homo-or heterozygosity at the identical insertion loci did not influence the overall DNA methylation pattern observed in the region.
Absence of DNA methylation at the endogenous ROSA26 counterpart of mouse genome
The ROSA26 promoter was derived from the 5′ regulatory region of exon 1 of the mouse R26 locus [30, 31] . If the endogenous ROSA26 sequence was inherently methylated in the mouse genome, the hypermethylation pattern observed in the ROSA26 portion of the T/MPT-eGFP in transgenic mice could be attributed to an intrinsic characteristic of ROSA26. Therefore, we examined the DNA methylation pattern of the endogenous counterpart of ROSA26 located on mouse chromosome 6. Specific bisulfite-PCR primers were used to differentiate the endogenous counterpart from the ROSA26 of the inserted SB Tn by selectively amplifying the endogenous genomic ROSA26 sequence in the same transgenic animals. Thus, the region examined by bisulfite-mediated sequencing had 5 more CpGs derived specifically from the endogenous ROSA26 in addition to the 36 in the 320-bp portion identical to the ROSA26 sequence carried by the inserted T/MPT-eGFP (Fig. 3) . Our results indicated that the 41 CpG dinucleotides in the endogenous ROSA26 at the native chromosomal locus were almost completely free of DNA methylation in all the transgenic animals as well as in the three individual wild-type FVB/n controls. Results from representative transgenic and wild-type animals are presented since bisulfite-sequencing data were, in fact, identical for the endogenous ROSA26 sequence in all the animals (Fig. 3) . In the 45 bisulfite-PCR subclones of the endogenous ROSA26 locus analyzed from three wild-type FVB/n mice, only 3 sporadic methylated CpGs were observed. The absence of CpG methylation at the endogenous ROSA26 loci was in sharp contrast to the high level of DNA methylation observed at the identical sequence within T/MPT-eGFP in the same animals ( Fig. 2) . The results clearly indicate that DNA methylation can be introduced selectively into SB Tns inserted in the mouse genome.
Hypomethylation at a neighboring host genomic region
The DNA methylation status of host genomic regions proximal to the inserted T/MPT-eGFP was characterized in several transgenic animals. T/MPT-eGFP insertion 01-0001 was located on chromosome 8 and had five CpG dinucleotides in the flanking ∼600 bp of genomic DNA. The methylation pattern of the five CpGs was assessed in the transgenic animal homozygous for the insertion 01-0001 and in three wild-type FVB/n mice without SB insertions (Fig. 4 ). This flanking region was significantly hypomethylated at all the CpGs adjacent to the 01-0001 insertion in the transgenic animal, compared to the identical region in the wild-type mice. This was in dramatic contrast to the high level of DNA methylation detected at the cargo sequence of T/MPT-eGFP (01-0001, Fig. 2 ). Moreover, unlike the different levels of methylation observed at the CpGs in the wild-type mice, the level of hypomethylation observed was consistent at all five CpGs. This suggests that the SB insertion triggered hypomethylation of the flanking genomic CpGs irrespective of their initial level of methylation or distance from the insertion site. The chromosomal DNA flanking the insertion 01-0001 on the opposite side was also investigated, and a similar pattern of CpG methylation was observed for both the transgenic animal and the wild-type controls (data not shown).
Loss of detectable CpG methylation in the genomic region flanking an SB insertion
More extensive hypomethylation was observed in the genomic region adjacent to the insertion 01-0032 on mouse chromosome 6 (Fig. 5) . Only DNA from transgenic animals heterozygous for this insertion was available because homozygous animals were embryonic lethal from the Tn insertion into an essential mitochondrial carrier protein-related gene [21] . To distinguish between the wild-type allele and that containing insertion 01-0032, bisulfite-PCR primers were designed to amplify only the 01-0032 insertion allele using one primer located in the Tn IR/DR sequence and the other enclosing the six CpGs within ∼190 bp adjacent to this insertion site. The IR/DR sequence amplified by this primer pair contained two CpGs so that the bisulfite-PCR subclones contained eight CpGs. The DNA methylation pattern of the wild-type allele was assessed using different bisulfite-PCR primers designed to span the identical neighboring region of 01-0032 without SB. Due to the size limitation of the bisulfite-mediated PCR, this primer set prevented amplification of the allele with the 3.2-kb T/MPTeGFP insertion. Thus, we were able to observe the methylation pattern of the six CpGs at different alleles of the identical genomic region in an individual transgenic animal. Interestingly, none of the eight CpGs were methylated in the 28 subclones derived from the primers specific for the flanking genomic region of the allele with the 01-0032 insertion (Fig. 5 ). In contrast, the wild-type allele in the same heterozygous transgenic mouse exhibited a moderate level of CpG methylation similar to that observed in the wild-type controls. The pattern of CpG methylation obtained from both the wild-type animals and the allele without the Tn clearly indicates that this region was normally methylated in the absence of an SB insertion. Hence, it appears that the mouse DNA methylation system can discriminate between identical host genomic sequences depending on the presence or absence of a nearby SB insertion. Together with the results from host genomic regions flanking the insertion 01-0001, our data suggest that SB transposition can induce either Fig. 2 . DNA methylation pattern of ROSA26 and the eGFP reporter gene of T/MPT-eGFP in the mouse genome. Bisulfite-mediated sequencing was applied to genomic DNA isolated from tail clips of each transgenic animal. The map of T/MPT-eGFP is located above the DNA methylation profiles. The region that was examined is indicated by expanded lines under the map. A roughly 500-bp stretch of DNA encompassing the 3′ portion of the ROSA26 promoter (∼320 bp) and initial part of the eGFP transgene (∼170 bp) was subjected to bisulfite sequencing. The region, included in a large CpG island, contained a total of 57 CpGs. Each horizontal line of circles in the profile represents a bisulfite-PCR subclone with filled circles and empty circles indicating methylated or unmethylated CpGs, respectively. Bisulfite-PCR subclones were grouped into a block of lines according to the transgenic mouse harboring different T/MPT-eGFP insertions. The genotype of the T/ MPT-eGFP insertion (homo-or heterozygous), insertion number, and chromosomal location for each transgenic animal are described at left. hypomethylation or complete demethylation of flanking host genomic DNA. In addition, the heavy DNA methylation observed in the T/MPT-eGFP at both chromosomal loci (Fig. 2) indicates a demarcating boundary(s) in the Tn beyond which CpG methylation is absent or rare.
CpG methylation at the flanking genomic regions of other insertions
Two other distinct chromosomal T/MPT-eGFP insertion loci were examined for possible changes in CpG methylation of the flanking regions (Fig. 6) . The bisulfite-PCR primer pair used to amplify the genomic region adjacent to insertion 01-0024 also amplified a portion of the IR/DR sequence of the Tn. At this locus the flanking chromosomal sequence displayed a DNA methylation pattern similar to that derived from wild-type animals (Fig. 6A) . The T/MPT-eGFP insertion 01-0041 also did not significantly influence the CpG methylation status of the adjacent host genomic DNA, as this region was densely methylated regardless of Tn presence (Fig. 6B) . Thus, the hypomethylation at the genomic regions of the insertions 01-0001 and 01-0032 was not universally observed for all T/MPT-eGFP transpositions.
Discussion
In this study, we applied bisulfite-mediated genomic sequencing to transgenic FVB/n mice carrying SB Tn insertions to identify potential changes in DNA methylation related to transposition into the mouse genome. Six independent insertions of Fig. 3 . CpG methylation at the endogenous counterpart of ROSA26 sequence located on mouse chromosome 6. Genomic DNA isolated from tail clips of each transgenic animal carrying T/MPT-eGFP insertions was subjected to bisulfite-mediated genomic sequencing. To discriminate the endogenous ROSA26 from that introduced by T/MPT-eGFP, a ROSA26-specific bisulfite-PCR primer was exploited, yielding bisulfite-PCR subclones containing five additional CpGs specific only to the endogenous ROSA26 sequence. Those five CpGs are indicated above the bisulfite-PCR subclones together with the 320-bp region identical with ROSA26 carried by T/MPT-eGFP. For annotations of the CpG methylation profile, see legend to Fig. 2 . DNA methylation of this endogenous ROSA26 was also assessed for transgenic animals heterozygous for insertion 01-0009 or insertion 01-0041 and two additional wild-type FVB/n mice. However, data from those animals also revealed the complete lack of DNA methylation as presented here and consequently are not shown.
the SB Tn, T/MPT-eGFP, were examined. Our results showed that SB Tns inserted into the mouse genome can be selectively methylated in marked contrast to the absence of CpG methylation in the identical DNA sequence at the endogenous chromosomal loci. In addition, our data also provide evidence for significant changes in the DNA methylation of the mouse genomic regions flanking SB insertion sites.
Foreign DNA elements such as retroviral LTRs have been reported to be susceptible to de novo DNA methylation when inserted into mammalian genomes [6, 7, 9] . This phenomenon was also observed in transgenic mouse strains generated by random integration of transgene arrays driven by various endogenous mouse promoters [39, 40] . In those studies, although the endogenous mouse promoter sequence was unmethylated, the identical DNA sequence integrated at various loci was methylated according to copy number of the transgene insertions. Fig. 5 . Lack of CpG methylation at the flanking host genomic region of the insertion 01-0032. A schematic map of the boundary region between the 01-0032 insertion and its adjacent host genomic region is indicated above the bisulfitesequencing data. The orientation of eGFP transcription is shown as an arrow followed by an IR/DR of SB (empty thick arrow). The target TA dinucleotide of SB insertion is also indicated. All six CpGs in the flanking region (vertical lines) were within ∼190 bp of the insertion site. To discriminate the allele carrying the insertion in the transgenic mouse heterozygous for the insertion 01-0032, one of the bisulfite-PCR primers was designed within the IR/DR sequence, thus enabling selective amplification of the insertion-carrying allele containing two CpGs in the IR/DR and six CpGs in the neighboring host region ∼190 bp from the insertion. Bisulfite-sequencing data for the allele without the insertion as well as wild-type animals were obtained by using a primer pair that could amplify only the region without insertion. For the annotations of bisulfite-sequencing data, see Fig. 2 legend. The p value calculated by χ 2 test with no methylation was <0.0001 for all the CpGs in the region. Thus, in this study, we investigated whether a similar methylation phenomenon was observed with single-copy transgene insertions into the mouse genome by SB transposase.
We compared the DNA methylation pattern of the ROSA26 promoter carried by an SB Tn (T/MPT-eGFP) directly with that of the endogenous ROSA26 sequence at its native chromosomal locus distinct from the SB insertion sites. The high level of CpG methylation of ROSA26 at the inserted T/MPT-eGFP was in marked contrast to the absence of CpG methylation at the identical endogenous ROSA26 sequence in the same transgenic animals. Therefore, our results provide solid evidence that a transposed SB Tn can be a specific target for epigenetic modification such as DNA methylation in the host genome. A previous study reported CpG methylation of a CAG-eGFP transgene cassette inserted into the host genome of mouse germ cells via SB transposition [41] . However, the CpG methylation of only two HpaII sites located at eGFP was described in that report, whereas our study examined the methylation status of 57 CpGs within T/MPT-eGFP. Furthermore, the synthetic CAG promoter used for the eGFP transgene [42, 43] had no identical mouse endogenous counterpart to which the DNA methylation pattern could be compared [41] . Our data demonstrate conclusively that differential methylation of the identical promoter sequence can result from SB-mediated transgene insertion into the genome.
Currently, many parameters could be considered critical for the discrimination of identical sequences by the DNA methylation system. The chromosomal locus of the T/MPT-eGFP insertion is not likely to be a crucial factor for the DNA methylation of ROSA26, since high levels of CpG methylation were detected in many different insertions of SB at a variety of chromosomal loci. We previously observed no significant level of CpG methylation at inserted SB Tns carrying a transgene comprised of a human K14 promoter and Agouti reporter gene in the C57BL/6 strain of inbred mice [44] . That finding, combined with the present results, suggests that the IR/DR sequences outside the SB Tn cargo DNA do not seem to influence CpG methylation status. In fact, the Agouti transgene was almost free of CpG methylation in the previous study. Therefore, the cargo sequence contained within the SB Tn most likely determines whether the inserted SB is susceptible to DNA methylation. Moreover, two of the T/MPT-eGFP insertions (01-0009 and 01-0024) displayed CpG methylation patterns implying a spread from the eGFP sequence as if it was the core sequence element triggering de novo DNA methylation. This is consistent with a recent report in which the eGFP reporter gene with its high CpG content mediated gene silencing through CpG dinucleotides [45] . Strain-specific epigenetic modification of the Tn cargo due to the genetic background of transgenic animals should also be considered. In part, this is because a different genetic background of inbred mouse strain was used in the previous study [44] , and the DNA methylation pattern of foreign transgenes appears to be modulated according to trans factors of the host genetic background [46, 47] . However, the clarification of precise mechanisms of CpG methylation by SB cargo sequence or host genetic backgrounds would require more comprehensive study with a variety of combinations of cargo sequences as well as different inbred host genetic backgrounds for the SB Tn.
The DNA methylation pattern of the 01-0024 Tn insertion appeared reminiscent of genomic imprinting patterns of DNA methylation, in that almost 50% of the bisulfite clones showed dense methylation and 50% showed relatively little CpG methylation. Characteristically, imprinted genes are located in clusters within the genome (http://www.mgu.har.mrc.ac.uk/ research/imprinting/largemap.html); and insertion 01-0024 is located in mouse chromosome 7 on which a number of imprinted loci exist. We examined a database of imprinted genes (http://www.otago.ac.nz/IGC) [48] to determine if insertion 01-0024 was, in fact, located near a block of imprinted genes. The closest region of genomic imprinting, with genes such as Snrpn and Necdin, was located ∼30 Mb from 01-0024, suggesting that the transgene was not located in that region of chromosome 7. However, another database of candidate genes (http://fantom2. gsc.riken.jp/EICODB/) [49] indicated that there are two maternally imprinted genes (RIKEN clone IDs F830048D03 and A130035I15) on chromosome 7 approximately 1 to 0.5 Mb from the insertion site. Within this distance, it is conceivable that methylation of Tn at the 01-0024 insertion site could be controlled by genomic imprinting. Unfortunately, as discussed below, insertion 01-0024 does not support expression of the eGFP reporter gene, making it impossible to analyze the imprinted pattern of this transgene. Moreover, in the FVB/n inbred strain, the genetic polymorphism that would be essential for allele-specific methylation or expression analysis is virtually absent. Thus, further out-crossing of the transgenic lines onto other strain backgrounds would be required to investigate genomic imprinting at this insertion site.
In addition to strain background effects, it has been reported that generational changes in the methylation status of a transgene array can be associated with its expression in transgenic mice [50, 51] . This suggests that the DNA methylation pattern of the inserted SB in the mouse genome could change due to reproduction of the transgenic lines. This issue will also need to be addressed by investigating multiple generations of the transgenic lines from the SB Tn founder mice.
A correlation between the expression of eGFP and CpG methylation of ROSA26 as well as eGFP itself is unclear because of the poly(A)-trap structure of T/MPT-eGFP. For eGFP expression, T/MPT-eGFP should be inserted into an intron since the transgene has no authentic poly(A) signal. Lack of a poly(A) tail would limit the stability of the transcript [52] . To obtain an appropriate poly(A) signal via splicing, the eGFP in T/MPTeGFP should be followed by an endogenous exon in correct transcriptional orientation. Among the SB insertions analyzed in this study, only two (01-0009 and 01-0032) had the correct insertional topology to support the splicing and production of polyadenylated eGFP reporter mRNA. For the insertion 01-0032, a fusion transcript between eGFP and the downstream exons was detected by RT-PCR in lung, thymus, and spleen of the heterozygous animal [21] . However, RT-PCR is so sensitive that the detected fusion transcript may have resulted from leaky transcriptional repression caused by the heavy DNA methylation observed in eGFP and ROSA26 of the insertion 01-0032. Additionally, DNA methylation at T/MPT-eGFP may explain the low level of eGFP expression detected in peripheral blood leukocytes of the transgenic founder animals used in this study [22] .
Another unique finding of our present study is the hypomethylation or no CpG methylation at the flanking host genomic sequences of certain SB Tn insertions. Wild-type levels of CpG methylation were either significantly reduced (insertion 01-0001) or completely absent (insertion 01-0032) at the flanking regions. However, the inserted SB elements were densely methylated. This suggests that the high level of DNA methylation within the inserted SB (T/MPT-eGFP) was unable to spread across the boundary between the SB Tn and the neighboring genomic regions. Previous reports have described demethylation at host genomic sequences with Rous sarcoma retroviral and Ad12 adenoviral DNA. Each displayed a close correlation between the CpG methylation status of the inserted viral genome and that of host flanking sequences [53, 54] , suggesting similar levels of demethylation. In our study, genomic alleles of the same chromosomal locus demonstrated sharply contrasting DNA methylation patterns in the same transgenic animal, depending on the presence of an SB insertion at the locus (Fig. 5, insertion 01-0032 ). This indicates that SB insertion could play a role as a genomic mark that enables the cellular epigenetic modification system to discriminate between alleles at the same chromosomal locus.
The parameters that can trigger demethylation at the hostflanking region are not entirely known. In fact, many of the T/ MPT-eGFP insertions retained DNA methylation levels and patterns similar to those of the wild-type controls. In addition, the insertion 01-0001 displayed hypomethylation at the flanking region adjacent to only one IR/DR, whereas another chromosomal region flanking the other IR/DR displayed a "wild-type" methylation pattern. Moreover, the alteration in methylation status of both the Tn and the flanking genomic regions was independent of whether the insertion was in a gene or within an intergenic region. The transition from hypermethylation to hypo-or demethylation must have occurred before the IR/DR of SB since two CpGs in the IR/DR of insertion 01-0032 displayed no CpG methylation at all. Thus, there must be a demarcating boundary in the T/MPT-eGFP with respect to DNA methylation for at least two T/MPT-eGFP insertions.
Recently, the SB transposon system was investigated as a potential tool for insertional random mutagenesis [21, 28] . With disruption of an exon and its ORF, one would not expect the methylation status of an integrated SB Tn to interfere with the mutagenesis screening. However, if SB insertion occurs in an intron or near a regulatory cis-element whose activity is closely associated with DNA methylation, phenotypic screening and correct mapping of the target gene could potentially be influenced by DNA methylation as previously observed [55] . Thus, random mutagenesis via SB insertion could generate a mutant phenotype resulting from cis methylation-dependent interference with gene expression independent of the Tn insertion site. Moreover, if gain-of-function occurs via expression of a new transcript from within the Tn intronic site of SB insertion [28] , promoter silencing by CpG methylation could modulate penetrance of the phenotype. This scenario for random mutagenesis suggests that the previously reported generational changes in the methylation status of a transgene array [50, 51] could affect the stability of the observed phenotype.
In conclusion, our study showed significant perturbation in the DNA methylation pattern of the inserted SB Tns as well as the flanking host genomic regions. The modification of DNA methylation may affect the expression of transgenes delivered by the SB Tn system and influence the local chromosomal transcriptional activity by changing the epigenetic structure of the chromatin as well. Thus, our findings warrant further study on a comprehensive scale to determine the potential epigenetic consequence(s) of nonviral DNA insertion into mammalian genomes.
Materials and methods
Transgenic animals
The transposon construct and transgenic animals were created as previously described [21, 22] . The poly(A)-trap Tn, T/MPT-eGFP, consists of a splice acceptor from the human HPRT intron B, a bovine growth hormone poly(A) sequence, the ROSA26 promoter [30, 31] driving the eGFP-F (enhanced and farnesylated green fluorescent protein) cDNA (from peGFP-F; Clontech Laboratories, Inc., Mountain View, CA, USA), and a splice donor from the rabbit β-globin gene. pCAGGS-SB10 encoding SB transposase was constructed with the SB10 transposase gene driven by the CAGGS promoter composed of chicken β-actin and cytomegalovirus immediate early promoter sequences [42, 43] . The linearized plasmid, pT/MPT-eGFP, was injected into the pronucleus of one-cell embryos together with SB10 mRNA. The FVB/n inbred mouse strain was used for the study, and transgenic lines carrying a multicopy concatemer of T/MPT-eGFP were established. Other FVB/n transgenic lines that expressed SB10 transposase ubiquitously were created with pCAGGS-SB10. By cross-breeding, doubly transgenic mice harboring T/MPT-eGFP and the SB10 transposase gene were generated. Subsequent breeding on the FVB/n background generated the transgenic mice used in this study, and chromosomal annotation of SB insertions was performed as described previously [21] .
Bisulfite-mediated genomic sequencing
Genomic DNA isolated from tail clips of the transgenic mice was digested with restriction endonucleases that did not cut the region of interest. This digestion reduced the overall length of the chromosomal DNA fragments to ensure complete DNA denaturation during bisulfite treatment. Following purification of the digested DNA, 2 μg of the recovered DNA was subjected to bisulfite treatment [29, 35, 36] . Briefly, DNA was denatured in 0.3 M NaOH for 20 min at 42°C. A mixture of sodium bisulfite (Sigma-Aldrich, Inc., St. Louis, MO, USA), urea [36] , and hydroquinone (Sigma-Aldrich) was added to the denatured DNA to final concentrations of 3.7 M sodium bisulfite, 5.8 M urea, and 8.8 mM hydroquinone. This mixture was incubated in the dark for ∼12-15 h at 55°C. DNA was subsequently purified using QIAEX II resin (Qiagen Corp., Chatsworth, CA, USA), treated with 0.3 M NaOH for 20 min at 37°C, and ethanol-precipitated overnight at −20°C using 3 M ammonium acetate, 1 μg of carrier tRNA (Sigma-Aldrich), and 3 vol of ethanol. The DNA was recovered by centrifugation at 13,000 g for 30 min at 4°C, washed twice with 70% ethanol, and finally resuspended in 30 μl of H 2 O. This material (∼2-4 μl) was used as template for the following PCR amplification of the DNA regions of interest.
PCR primers for bisulfite-treated genomic DNA were designed from DNA sequences converted by the Methprimer program [37] , which converts every C to T except C's in the CpG dinucleotides. Bisulfite PCR primers for ROSA26 and eGFP in T/MPT-eGFP were ROSAF4 (forward), 5′-TYGGTATTATTGTGTTG-GYGGATTGG-3′ (Y = C or T), and MPTR1 (reverse), 5′-ACAAATAAACTT-CAAAATCAACTTACC-3′; primers for the endogenous counterpart of ROSA26 were ROSAF4 (above, forward) and EndoRR2 (reverse), 5′-ACTATCTCA-CAAAACRACTCCACCAC-3′ (R = G or A); those for the flanking genomic region of the insertion 01-0001 were 0001F1 (forward), 5′-GAAATTAGGTTT-TAATGAAGAGTAGTG-3′, and 0001R1 (reverse), 5′-CTTACCAAATACC-CAATATTTATTCC-3′; primers for a part of the IR/DR and flanking genomic region of the insertion 01-0032 were MPTSBF3 (forward), 5′-GATTTGTGT-TATGTATAAAGTAGATG-3′, and 0032R (reverse), 5′-ACAATAAACTAT-CCTCTACATTAACC-3′; those for the flanking region of 01-0032 with no insertion were 32WTF (forward), 5′-GGTTAGTTATTATAGTGTTAGAAGG-3′, and 0032R (above, reverse); primers for the flanking IR/DR and adjacent host genomic region of the insertion 01-0024 were RIROF (forward), 5′-GAA-TGTGATGAAAGAAATAAAAGTTG-3′, and 24WTR (reverse), 5′-CAATAA-CATATTACAATAAACACTTAC-3′; primers for the wild-type flanking region of 01-0024 with no insertion were 24WTF3 (forward), 5′-TATAATGATTTA-GTTAGTTGAAATTTG-3′, and 24WTR2 (reverse), 5′-TATACTATATAACA-CACTACAACCTC-3′; and primers for the flanking genomic region of insertion 01-0041 were 0041F (forward), 5′-TGGTTGTAGAAGATTTAAAGTATAAG-3′, and 0041R (reverse), 5′-TCATCCTTCAAAAACCCTTCCAATC-3′. PCRs were performed with the Expand High Fidelity PCR system (Roche Diagnostics, Inc., Indianapolis, IN, USA) and Touchgene Gradient thermal cycler (Techne, Inc., Burlington, NJ, USA). All PCRs employed a hot start and used PCR cycles consisting of 5 min at 94°C, 36 cycles of 25 s at 94°C, 20 s at 55°C, and 45 s at 72°C and a final extension of 5 min at 72°C. The primer annealing temperature used for the PCR amplification of the DNA from the wild-type mice flanking the insertion 01-0024 (24WTF3 and 24WTR2) was 53°C, not the usual 55°C.
PCR products were purified using the QIAquick gel extraction kit (Qiagen) and subsequently subcloned into the pGEM-T Easy vector (Promega Corp., Madison, WI, USA). Bisulfite-PCR subclones were sequenced using the standard SP6 upstream primer. All cytosine residues except those of CpG dinucleotides in the DNA regions amplified were examined for complete conversion to thymine residues. Rare bisulfite-PCR subclones demonstrating unconverted cytosine residues not from CpG dinucleotides were excluded.
Statistical analysis
Data from wild-type animals was assumed to be representative of the "normal" pattern of CpG methylation at the relevant region. Statistical analysis using the χ 2 test was performed to determine if the wild-type loci methylation densities differed significantly from those present in the chromosomal regions flanking the insertion sites. p ≤ 0.05 was considered significant.
